• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR Back to Search Results
Model Number PELORIS II
Device Problem Application Program Problem: Parameter Calculation Error (1449)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/29/2019
Event Type  malfunction  
Manufacturer Narrative
Sub-optimal tissue processing was identified from the following two (2) protocols: the "gi 1hr" protocol comprising 34 cassettes was started in retort b at 12:39pm on (b)(6) 2019 and completed at 13:56pm on (b)(6) 2019; and the "gi 1hr" protocol comprising eight (8) cassettes started in retort a at 11:18am on (b)(6) 2019 and completed at 12:35pm on (b)(6) 2019.The instrument functioned as designed when processing of tissue samples from the "gi 1hr" protocol started in retort b at 12:39pm on (b)(6) 2019 was paused intermittently between 12:43pm on (b)(6) 2019 to 13:05pm on (b)(6) 2019 because the condensate bottle was intermittently not in contact with the corresponding sensor during this period.Steps 2 to 13 of the gi 1hr" protocol started in retort b at 12:39pm on (b)(6) 2019 were subsequently completed between 13:07pm and 13:56pm on (b)(6) 2019 at a reduced duration in order to meet the end time calculated by the software scheduler.The root cause of the sub-optimal tissue processing reported by the complainant from the "gi 1hr" protocol started in retort b at 12:39pm on (b)(6) 2019 was insufficient dehydration and clearing of the tissue samples involved as a consequence of the 12 remaining processing steps being executed in 49 minutes in an attempt to meet the end time calculated by the software scheduler.The root cause of the condensate bottle moving out of contact with the corresponding sensor could not be unequivocally determined from the information available the instrument operated within specification during execution of the "gi 1hr" protocol started in retort a at 11:18am on (b)(6) 2019.The root cause of the sub-optimal tissue processing reported by the complainant from the "gi 1hr" protocol started in retort a at 11:18am on (b)(6) 2019 could not be determined from the information available.
 
Event Description
On (b)(6) 2019, leica biosystems received a complaint detailing the following: "wax changed in wax 1 on apr 16, still at 100% but has been used several times since, doesn't think processor is counting concentration correctly.Should have degraded to 98 by now.Just changes wax 3 which was at 92% but wax solidifying incompletely (slimy with added carry over solvent?)" on (b)(6) 2019, a leica field service engineer (fse) visited the customer site in relation to the customer complaint regarding wax degradation.The fse documented the following: "in addition, tissue was underprocessed on run made on (b)(6) at 12:26." on (b)(6) 2019, a leica applications specialist-core histology (fss) telephoned the complainant and documented the following: "two short gi ihr protocols-one on (b)(6) and one on (b)(6)-ended with some of the larger fatty specimens appearing squishy and exploded when they were placed on the water bath.Appeared underprocessed.On (b)(6) at 12:26 a protocol was run on retort that left the specimens squishy, i.E, not dehydrated.The customer reported that after the protocol they checked reagent container 11 (xylene) which did not smell very much like xylene.They replaced the reagent immediately, before leica rep could check." the fss also documented that the customer reported that the condensate bottle caused a warning message to be displayed even though the bottle was properly inserted.On (b)(6) 2019, the fss received information that all cases involved in this event were diagnosable.(this information was received by leica biosystems (b)(4) on 09 may 2019.).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS RAPID TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD
495 blackburn road
mount waverley, 3149
AS  3149
Manufacturer (Section G)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD
495 blackburn road
mount waverley, 3149
AS   3149
Manufacturer Contact
adrienne hardisty
495 blackburn road
mount waverley, 3149
AS   3149
MDR Report Key8656979
MDR Text Key209394958
Report Number8020030-2019-00019
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/31/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberPELORIS II
Device Catalogue Number26.0008
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/01/2019
Initial Date FDA Received05/31/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/05/2010
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-